BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
| 5.82 BATS BZX Real-Time Price As of 2:02pm ET |  +0.385 / +7.09%Today’s Change | 4.83 Today|||52-Week Range 13.49 | -49.35% Year-to-Date |
Latest BCRX News | Press Releases
No recent news for BioCryst Pharmaceuticals Inc.
Today’s Trading
| Previous close | 5.43 |
| Today’s open | 5.62 |
| Day’s range | 5.58 - 5.85 |
| Volume | 82,275 |
| Average volume (3 months) | 2,886,060 |
| Market cap | $1.1B |
Data as of 2:02pm ET, 11/30/2023
Growth & Valuation
| Earnings growth (last year) | -29.35% |
| Earnings growth (this year) | +28.23% |
| Earnings growth (next 5 years) | +29.97% |
| Revenue growth (last year) | +72.31% |
| P/E ratio | NM |
| Price/Sales | 7.88 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PTGXProtagonist Therapeu... | +0.38 | +2.15% |
| WVEWAVE Life Sciences L... | -0.05 | -0.95% |
| NVAXNovavax Inc | -0.02 | -0.36% |
| RAPTRAPT Therapeutics In... | -0.04 | -0.27% |
Data as of 2:06pm ET, 11/30/2023
Financials
| Next reporting date | February 21, 2024 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $270.8M |
| Annual profit (last year) | -$247.1M |
| Net profit margin | -91.24% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
